Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mengdi He
Institution:
Chengdu University of Traditional Chinese Medicine
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Obstetrics and Gynecology Hospital of Fudan University,
Chengdu University of Traditional Chinese Medicine
ORCID:
0000-0003-2693-5261
Observed ORCID:
0000-0003-2693-5261
OpenAlex ID:
A5023688712
CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer
2021
·
Moran Yang
, Jiaqi Lu
, et al.
·
Journal for ImmunoTherapy of Cancer
·
265
PDF
Tumour-associated neutrophils orchestrate intratumoural IL-8-driven immune evasion through Jagged2 activation in ovarian cancer
2020
·
Moran Yang
, Guodong Zhang
, et al.
·
British Journal of Cancer
·
84
PDF
The immune landscape during the tumorigenesis of cervical cancer
2021
·
Yiying Wang
, Mengdi He
, et al.
·
Cancer Medicine
·
49
Stromal infiltrating mast cells identify immunoevasive subtype high-grade serous ovarian cancer with poor prognosis and inferior immunotherapeutic response
2021
·
Kankan Cao
, Guodong Zhang
, et al.
·
OncoImmunology
·
49
C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancer
2023
·
Chen Zhang
, Kankan Cao
, et al.
·
OncoImmunology
·
43
Attenuation of Sialylation Augments Antitumor Immunity and Improves Response to Immunotherapy in Ovarian Cancer
2023
·
Kankan Cao
, Guodong Zhang
, et al.
·
Cancer Research
·
38
Mannose Enhances Immunotherapy Efficacy in Ovarian Cancer by Modulating Gut Microbial Metabolites
2025
·
Chen Zhang
, Yiying Wang
, et al.
·
Cancer Research
·
37
Siglec-9+ tumor-associated macrophages delineate an immunosuppressive subset with therapeutic vulnerability in patients with high-grade serous ovarian cancer
2023
·
Yiying Wang
, Mengdi He
, et al.
·
Journal for ImmunoTherapy of Cancer
·
37
PDF
Immunosuppressive JAG2 + tumor‐associated neutrophils hamper PD‐1 blockade response in ovarian cancer by mediating the differentiation of effector regulatory T cells
2025
·
Chenyang Wang
, Moran Yang
, et al.
·
癌症:英文版
·
23
The prognostic significance of tumor-infiltrating lymphocytes in cervical cancer
2021
·
Mengdi He
, Yiying Wang
, et al.
·
Journal of Gynecologic Oncology
·
23
Spatial cytotoxic and memory T cells in tumor predict superior survival outcomes in patients with high‐grade serous ovarian cancer
2021
·
Guodong Zhang
, Qing Xu
, et al.
·
Cancer Medicine
·
15
PDF
Effects of total glucosides of paeony on serum inflammatory cytokines in animal models of rheumatoid arthritis: a systematic review and meta-analysis
2024
·
Mengdi He
, Zhipeng Hu
, et al.
·
Frontiers in Pharmacology
·
10
Data from Mannose Enhances Immunotherapy Efficacy in Ovarian Cancer by Modulating Gut Microbial Metabolites
2025
·
Chen Zhang
, Yiying Wang
, et al.
·
1
Renal protective effects and mechanisms of tripterygium glycosides in animal models of diabetic nephropathy: a preclinical systematic review and meta-analysis
2026
·
Mengdi He
, Weiyi Feng
, et al.
·
Frontiers in Pharmacology
Supplementary Data from Attenuation of Sialylation Augments Antitumor Immunity and Improves Response to Immunotherapy in Ovarian Cancer
2025
·
Kankan Cao
, Guodong Zhang
, et al.
Supplementary Data from Attenuation of Sialylation Augments Antitumor Immunity and Improves Response to Immunotherapy in Ovarian Cancer
2025
·
Kankan Cao
, Guodong Zhang
, et al.
Supplementary Table S1 from Mannose Enhances Immunotherapy Efficacy in Ovarian Cancer by Modulating Gut Microbial Metabolites
2025
·
Chen Zhang
, Yiying Wang
, et al.
Supplementary Figure S10 from Mannose Enhances Immunotherapy Efficacy in Ovarian Cancer by Modulating Gut Microbial Metabolites
2025
·
Chen Zhang
, Yiying Wang
, et al.
Supplementary Figure S5 from Mannose Enhances Immunotherapy Efficacy in Ovarian Cancer by Modulating Gut Microbial Metabolites
2025
·
Chen Zhang
, Yiying Wang
, et al.
Supplementary Figure S6 from Mannose Enhances Immunotherapy Efficacy in Ovarian Cancer by Modulating Gut Microbial Metabolites
2025
·
Chen Zhang
, Yiying Wang
, et al.
Supplementary Figure S8 from Mannose Enhances Immunotherapy Efficacy in Ovarian Cancer by Modulating Gut Microbial Metabolites
2025
·
Chen Zhang
, Yiying Wang
, et al.
Supplementary Figure S2 from Mannose Enhances Immunotherapy Efficacy in Ovarian Cancer by Modulating Gut Microbial Metabolites
2025
·
Chen Zhang
, Yiying Wang
, et al.
Supplementary Table S2 from Mannose Enhances Immunotherapy Efficacy in Ovarian Cancer by Modulating Gut Microbial Metabolites
2025
·
Chen Zhang
, Yiying Wang
, et al.
Supplementary Figure S3 from Mannose Enhances Immunotherapy Efficacy in Ovarian Cancer by Modulating Gut Microbial Metabolites
2025
·
Chen Zhang
, Yiying Wang
, et al.
Supplementary Figure S9 from Mannose Enhances Immunotherapy Efficacy in Ovarian Cancer by Modulating Gut Microbial Metabolites
2025
·
Chen Zhang
, Yiying Wang
, et al.
Show more works
View as search
Works count:
45
Citation count:
674
H-index:
11
I10-index:
12
Year
Topic
Type